MoneyWorks4Me

Beryl Drugs informs about financial results

14 Nov 2018 Evaluate

Pursuant to Regulation 30 read with Part- A of Schedule lll of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Beryl Drugs has informed that the Board of Directors in its Board Meeting held on November 13, 2018 has approved the Unaudited Financial Results of the company for the Quarter/ Half year ended 30th September, 2018.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1847.00
Dr. Reddys Labs. 1211.30
Cipla 1368.50
Lupin 2120.60
Zydus Lifesciences 1170.00
View more..